Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 26 | 2025 | 811 | 1.880 |
Why?
|
| Graft Rejection | 24 | 2025 | 1120 | 1.460 |
Why?
|
| Transplantation Tolerance | 13 | 2025 | 143 | 1.450 |
Why?
|
| Gastric Bypass | 3 | 2022 | 114 | 1.310 |
Why?
|
| CD40 Ligand | 10 | 2025 | 77 | 1.170 |
Why?
|
| B-Lymphocytes | 12 | 2021 | 701 | 1.020 |
Why?
|
| Mice, Inbred C57BL | 26 | 2025 | 3435 | 0.880 |
Why?
|
| Insulin Resistance | 2 | 2022 | 379 | 0.880 |
Why?
|
| Mice | 47 | 2025 | 12269 | 0.830 |
Why?
|
| Obesity | 5 | 2022 | 1018 | 0.790 |
Why?
|
| Diet, High-Fat | 3 | 2022 | 135 | 0.720 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2023 | 481 | 0.720 |
Why?
|
| Isoenzymes | 3 | 2013 | 272 | 0.710 |
Why?
|
| Protein Kinase C | 3 | 2013 | 261 | 0.710 |
Why?
|
| Mice, Inbred BALB C | 15 | 2024 | 1101 | 0.650 |
Why?
|
| Transplantation, Heterologous | 6 | 2004 | 371 | 0.650 |
Why?
|
| Animals | 51 | 2025 | 28155 | 0.610 |
Why?
|
| Bile | 1 | 2019 | 60 | 0.590 |
Why?
|
| Antibodies, Monoclonal | 10 | 2023 | 1395 | 0.580 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 123 | 0.560 |
Why?
|
| Transplantation, Homologous | 14 | 2025 | 1014 | 0.560 |
Why?
|
| Isoantibodies | 7 | 2021 | 127 | 0.550 |
Why?
|
| T-Lymphocytes | 11 | 2021 | 1275 | 0.530 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 244 | 0.510 |
Why?
|
| Bile Acids and Salts | 2 | 2020 | 77 | 0.510 |
Why?
|
| Galactosyltransferases | 7 | 2004 | 42 | 0.500 |
Why?
|
| Jejunum | 1 | 2016 | 76 | 0.480 |
Why?
|
| Pancreas Transplantation | 2 | 2008 | 104 | 0.450 |
Why?
|
| Energy Metabolism | 2 | 2016 | 299 | 0.430 |
Why?
|
| NF-kappa B | 4 | 2023 | 408 | 0.410 |
Why?
|
| Adipose Tissue | 1 | 2016 | 270 | 0.400 |
Why?
|
| Gastrointestinal Tract | 2 | 2016 | 195 | 0.400 |
Why?
|
| Graft Survival | 9 | 2025 | 937 | 0.390 |
Why?
|
| Immunologic Memory | 8 | 2024 | 184 | 0.380 |
Why?
|
| Spleen | 4 | 2016 | 374 | 0.380 |
Why?
|
| Mice, Knockout | 19 | 2020 | 2121 | 0.370 |
Why?
|
| Bone Transplantation | 2 | 2003 | 79 | 0.360 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2024 | 660 | 0.350 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 24 | 0.340 |
Why?
|
| Skin Transplantation | 4 | 2024 | 191 | 0.340 |
Why?
|
| Basement Membrane | 1 | 2011 | 57 | 0.330 |
Why?
|
| Immune Tolerance | 9 | 2025 | 375 | 0.330 |
Why?
|
| Abatacept | 4 | 2020 | 87 | 0.320 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 464 | 0.310 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2023 | 207 | 0.300 |
Why?
|
| Isoantigens | 4 | 2023 | 72 | 0.290 |
Why?
|
| Oligonucleotides | 1 | 2009 | 92 | 0.290 |
Why?
|
| Blood Glucose | 5 | 2020 | 867 | 0.290 |
Why?
|
| CpG Islands | 1 | 2009 | 168 | 0.290 |
Why?
|
| Kidney | 4 | 2011 | 1111 | 0.290 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 208 | 0.280 |
Why?
|
| Luminescence | 1 | 2008 | 20 | 0.280 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2006 | 201 | 0.270 |
Why?
|
| Liver | 2 | 2009 | 1210 | 0.250 |
Why?
|
| Mice, Inbred C3H | 5 | 2009 | 369 | 0.250 |
Why?
|
| Insulin-Secreting Cells | 2 | 2006 | 441 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2008 | 589 | 0.230 |
Why?
|
| Rats, Inbred Lew | 7 | 2008 | 214 | 0.230 |
Why?
|
| Lymphocyte Activation | 5 | 2016 | 797 | 0.220 |
Why?
|
| Disaccharides | 4 | 2008 | 24 | 0.220 |
Why?
|
| Interferon-gamma | 4 | 2016 | 460 | 0.210 |
Why?
|
| Lymphocytes | 4 | 2009 | 454 | 0.210 |
Why?
|
| Phenotype | 4 | 2019 | 2544 | 0.210 |
Why?
|
| Phenanthrenes | 1 | 2023 | 4 | 0.200 |
Why?
|
| Mice, Transgenic | 7 | 2025 | 1587 | 0.200 |
Why?
|
| Diterpenes | 1 | 2023 | 24 | 0.200 |
Why?
|
| Killer Cells, Natural | 2 | 2008 | 286 | 0.200 |
Why?
|
| Major Histocompatibility Complex | 1 | 2023 | 86 | 0.200 |
Why?
|
| Prodrugs | 1 | 2023 | 51 | 0.200 |
Why?
|
| Protein Kinase C-theta | 3 | 2013 | 16 | 0.190 |
Why?
|
| Rats | 9 | 2023 | 4072 | 0.190 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2025 | 277 | 0.180 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1194 | 0.180 |
Why?
|
| Interleukin-10 | 1 | 2003 | 163 | 0.180 |
Why?
|
| Mice, Obese | 1 | 2022 | 49 | 0.180 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2025 | 337 | 0.180 |
Why?
|
| Signal Transduction | 5 | 2023 | 3502 | 0.170 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 124 | 0.170 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 281 | 0.170 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2021 | 11 | 0.170 |
Why?
|
| Immunoconjugates | 1 | 2002 | 129 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2023 | 171 | 0.160 |
Why?
|
| Allografts | 3 | 2021 | 205 | 0.160 |
Why?
|
| Germinal Center | 1 | 2020 | 62 | 0.160 |
Why?
|
| Fetus | 1 | 2021 | 236 | 0.150 |
Why?
|
| Parenteral Nutrition | 1 | 2020 | 64 | 0.150 |
Why?
|
| Stomach | 1 | 2020 | 113 | 0.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 149 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 2495 | 0.140 |
Why?
|
| Kinetics | 3 | 2016 | 1492 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 163 | 0.140 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2016 | 35 | 0.140 |
Why?
|
| Adoptive Transfer | 4 | 2008 | 172 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2020 | 243 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 715 | 0.130 |
Why?
|
| CTLA-4 Antigen | 3 | 2009 | 144 | 0.130 |
Why?
|
| Glucose | 1 | 2020 | 692 | 0.130 |
Why?
|
| Central Tolerance | 1 | 2016 | 8 | 0.120 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2023 | 103 | 0.120 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 990 | 0.120 |
Why?
|
| Adipokines | 1 | 2016 | 18 | 0.120 |
Why?
|
| Gastrointestinal Hormones | 1 | 2016 | 8 | 0.120 |
Why?
|
| Adiposity | 1 | 2016 | 76 | 0.120 |
Why?
|
| Antigens, CD | 3 | 2009 | 476 | 0.120 |
Why?
|
| Thermogenesis | 1 | 2016 | 46 | 0.120 |
Why?
|
| Time Factors | 6 | 2016 | 5410 | 0.120 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 145 | 0.120 |
Why?
|
| Receptors, IgG | 2 | 2008 | 68 | 0.120 |
Why?
|
| Complement Activation | 2 | 2008 | 84 | 0.120 |
Why?
|
| Swine | 5 | 2004 | 588 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2016 | 321 | 0.110 |
Why?
|
| Lipids | 1 | 2016 | 278 | 0.110 |
Why?
|
| Trisaccharides | 3 | 2003 | 12 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 870 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 78 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 590 | 0.100 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2006 | 247 | 0.100 |
Why?
|
| Male | 10 | 2025 | 44557 | 0.100 |
Why?
|
| Rituximab | 1 | 2013 | 128 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 2303 | 0.090 |
Why?
|
| Listeriosis | 2 | 2015 | 90 | 0.090 |
Why?
|
| Listeria monocytogenes | 2 | 2015 | 97 | 0.090 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2012 | 5 | 0.090 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2009 | 73 | 0.090 |
Why?
|
| Antibody Formation | 3 | 2020 | 169 | 0.090 |
Why?
|
| Transplantation, Heterotopic | 4 | 2009 | 47 | 0.090 |
Why?
|
| Seminiferous Tubules | 1 | 2011 | 8 | 0.090 |
Why?
|
| Epididymis | 1 | 2011 | 19 | 0.090 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2011 | 18 | 0.080 |
Why?
|
| Mice, Inbred NOD | 2 | 2008 | 216 | 0.080 |
Why?
|
| Weight Loss | 1 | 2012 | 234 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1741 | 0.080 |
Why?
|
| Bronchi | 1 | 2011 | 225 | 0.080 |
Why?
|
| Mice, Inbred Strains | 2 | 2015 | 280 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2011 | 756 | 0.070 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 36 | 0.070 |
Why?
|
| Inflammation | 2 | 2016 | 1050 | 0.070 |
Why?
|
| Cytokines | 2 | 2002 | 863 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 436 | 0.070 |
Why?
|
| Luciferases | 1 | 2008 | 129 | 0.070 |
Why?
|
| Immunoglobulin M | 3 | 2002 | 153 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2009 | 712 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2011 | 700 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 287 | 0.060 |
Why?
|
| Female | 12 | 2024 | 48702 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 232 | 0.060 |
Why?
|
| Epitopes | 2 | 2004 | 254 | 0.060 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 25 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2006 | 46 | 0.060 |
Why?
|
| Injections, Intravenous | 2 | 2003 | 212 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 608 | 0.060 |
Why?
|
| Cell Differentiation | 3 | 2006 | 1621 | 0.060 |
Why?
|
| Pregnancy | 2 | 2024 | 3147 | 0.060 |
Why?
|
| Acute Disease | 2 | 2009 | 841 | 0.060 |
Why?
|
| Recurrence | 1 | 2008 | 1190 | 0.050 |
Why?
|
| Isoxazoles | 1 | 2005 | 78 | 0.050 |
Why?
|
| Cytomegalovirus Infections | 1 | 2005 | 111 | 0.050 |
Why?
|
| Histocompatibility | 1 | 2004 | 66 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2023 | 10 | 0.050 |
Why?
|
| Galactose | 1 | 2003 | 31 | 0.050 |
Why?
|
| Immune Sera | 1 | 2003 | 48 | 0.050 |
Why?
|
| Clonal Deletion | 1 | 2003 | 23 | 0.050 |
Why?
|
| Cloning, Organism | 1 | 2003 | 19 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2003 | 46 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 102 | 0.050 |
Why?
|
| Ricin | 1 | 2002 | 6 | 0.050 |
Why?
|
| beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase | 1 | 2002 | 2 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2006 | 1723 | 0.050 |
Why?
|
| Transplantation Chimera | 1 | 2002 | 84 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2002 | 145 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2005 | 364 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 93515 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 2002 | 83 | 0.040 |
Why?
|
| Antigens | 1 | 2002 | 224 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2002 | 167 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2002 | 149 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 436 | 0.040 |
Why?
|
| Myocardium | 1 | 2004 | 570 | 0.040 |
Why?
|
| Apoptosis | 2 | 2023 | 1721 | 0.040 |
Why?
|
| Body Weight | 2 | 2016 | 449 | 0.040 |
Why?
|
| Peptides | 1 | 2023 | 656 | 0.040 |
Why?
|
| Bortezomib | 1 | 2020 | 82 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2020 | 91 | 0.040 |
Why?
|
| Cholestasis | 1 | 2020 | 44 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 555 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2003 | 541 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 362 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2020 | 276 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 767 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 2755 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2016 | 14 | 0.030 |
Why?
|
| Thymocytes | 1 | 2016 | 31 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 2016 | 25 | 0.030 |
Why?
|
| Integrases | 1 | 2016 | 66 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2016 | 30 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 67 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2002 | 761 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 141 | 0.030 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2015 | 11 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 14 | 0.030 |
Why?
|
| Hybridomas | 2 | 2008 | 61 | 0.030 |
Why?
|
| Autoantigens | 1 | 2016 | 138 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 829 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 2910 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 2479 | 0.030 |
Why?
|
| Heart | 1 | 2016 | 522 | 0.020 |
Why?
|
| Immunization | 2 | 2004 | 154 | 0.020 |
Why?
|
| Models, Animal | 2 | 2004 | 282 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 1866 | 0.020 |
Why?
|
| Interleukin-2 | 2 | 2002 | 244 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1985 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 162 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 382 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 878 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 28 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2012 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2008 | 54 | 0.020 |
Why?
|
| Cell Line | 2 | 2003 | 2464 | 0.020 |
Why?
|
| Bystander Effect | 1 | 2008 | 14 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2008 | 28 | 0.020 |
Why?
|
| Hemolysin Proteins | 1 | 2008 | 32 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2008 | 71 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2008 | 58 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2008 | 101 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2008 | 122 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2008 | 86 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 112 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2008 | 102 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 178 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2008 | 164 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 1004 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2006 | 271 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 309 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 2005 | 37 | 0.010 |
Why?
|
| Alkynes | 1 | 2005 | 21 | 0.010 |
Why?
|
| Regeneration | 1 | 2006 | 159 | 0.010 |
Why?
|
| Uridine | 1 | 2005 | 54 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 556 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2006 | 189 | 0.010 |
Why?
|
| Nitriles | 1 | 2005 | 154 | 0.010 |
Why?
|
| Membranes | 1 | 2004 | 35 | 0.010 |
Why?
|
| Virus Replication | 1 | 2005 | 284 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 387 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 2003 | 38 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 2003 | 19 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2850 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2003 | 47 | 0.010 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2003 | 15 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 2003 | 38 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 2003 | 59 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 2002 | 39 | 0.010 |
Why?
|
| Antigens, Heterophile | 1 | 2002 | 6 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 217 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2003 | 239 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2002 | 134 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 10164 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 1028 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 557 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 348 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 608 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 756 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 664 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2003 | 338 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 740 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1234 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 27573 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 27918 | 0.010 |
Why?
|